Juan Guio, Andrés Melo, Mateo Mejía Saldarriaga, Cynthia Fuentes, Natalia Tíjaro-Ovalle, Andrés Borda, Yuli Guzmán, Elías Bolaños, Guillermo Quintero, Mónica Duarte, Claudia Agudelo, Soraya Aparicio, Gina Cuellar, Patricia Bernal, Marco Paéz, Erica Rueda, Agustina Rodriguez, Fernando Alvarado, Oscar Pinzón, Martha Romero
Multiple myeloma, the second most common hematologic malignancy worldwide, is an aggressive disease with high morbidity and mortality rates. Although myeloma remains incurable, new treatments have improved patients' life expectancy and quality of life. However, as these therapies are administered for prolonged and often indefinite periods, their success depends on high treatment adherence and significant patient engagement. This study aimed to evaluate the impact of a novel digital educational strategy on treatment adherence, quality of life, and the development of complications in patients with newly diagnosed myeloma...
February 2024: Journal of Cancer Education: the Official Journal of the American Association for Cancer Education